NAGE
Niagen Bioscience, Inc. Common Stock
NAGE
NAGE
101 hedge funds and large institutions have $201M invested in Niagen Bioscience, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
101
Holders Change
+5
Holders Change %
+5.21%
% of All Funds
1.76%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
19
Increased
37
Reduced
28
Closed
14
Calls
$7.43M
Puts
$3.95M
Net Calls
+$3.49M
Net Calls Change
+$4.54M
Top Buyers
| 1 |
Barclays
London,
United Kingdom
|
+$7.64M |
| 2 |
JPMPWA
J.P. Morgan Private Wealth Advisors
San Francisco,
California
|
+$2.65M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.63M |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$2.04M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.05M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$7.96M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$7.89M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$5.19M |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$3.66M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.54M |
